{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:08:48Z","timestamp":1763057328957},"reference-count":20,"publisher":"Oxford University Press (OUP)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transactions of the Royal Society of Tropical Medicine and Hygiene"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.trstmh.2006.02.009","type":"journal-article","created":{"date-parts":[[2006,6,6]],"date-time":"2006-06-06T22:54:32Z","timestamp":1149634472000},"page":"S41-S44","source":"Crossref","is-referenced-by-count":29,"special_numbering":"S1","title":["Miltefosine: issues to be addressed in the future"],"prefix":"10.1093","volume":"100","author":[{"given":"J.","family":"Berman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.D.M.","family":"Bryceson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Croft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Engel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Gutteridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Karbwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Sindermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Urbina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1016\/j.trstmh.2006.02.009_bib1","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1046\/j.1365-3156.2001.00795.x","article-title":"A policy for leishmaniasis with respect to the prevention and control of drug resistance","volume":"6","author":"Bryceson","year":"2001","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.trstmh.2006.02.009_bib2","first-page":"139","article-title":"Antiprotozoal lysophospholipid analogues: a comparison of their activity against Trypanosomatid parasites and tumor cells","volume":"4","author":"de Castro","year":"2004","journal-title":"Mini-Revs Med. Chem."},{"key":"10.1016\/j.trstmh.2006.02.009_bib3","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.2174\/1381612054864920","article-title":"Dihydro-beta-agarofuran sesquiterpenes: a new class of reversal agents of the multidrug resistance phenotype mediated by P-glycoprotein in the protozoan parasite Leishmania","volume":"11","author":"Cortes-Selva","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.trstmh.2006.02.009_bib4","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.bbrc.2005.02.009","article-title":"Functional expression of a multidrug P-glycoprotein transporter of Leishmania","volume":"329","author":"Cortes-Selva","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.trstmh.2006.02.009_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0001-706X(01)00197-8","article-title":"Sensitivities of Leishmania species to exadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B","volume":"81","author":"Escobar","year":"2002","journal-title":"Acta Trop."},{"key":"10.1016\/j.trstmh.2006.02.009_bib6","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1056\/NEJM199912093412411","article-title":"Miltefosine \u2013 the long-awaited therapy for visceral leishmaniasis?","volume":"341","author":"Herwaldt","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trstmh.2006.02.009_bib7","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/jac\/47.5.537","article-title":"Mechanism of action of antiproliferative alkyl-lysophospholipids against the protozoan parasite Trypanosoma cruzi. Potentiation of in vitro activity by the sterol biosynthesis inhibitor ketoconazole","volume":"47","author":"Lira","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.trstmh.2006.02.009_bib8","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1158\/0008-5472.CAN-04-1005","article-title":"Celastraceae sesquiterpenes as a new class of modulators that bind specifically to human P-glycoprotein and reverse cellular multidrug resistance","volume":"64","author":"Munoz-Martinez","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.trstmh.2006.02.009_bib9","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1128\/AAC.45.9.2468-2474.2001","article-title":"Alkyl-lysophospholipid resistance in multidrug-resistant Leishmania tropica and chemosensitization by a novel P-glycoprotein-like transporter modulator","volume":"45","author":"Perez-Victoria","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.trstmh.2006.02.009_bib10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2174\/1389450023347588","article-title":"Multidrug resistance phenotype mediated by the P-glycoprotein-like transporter in Leishmania: a search for reversal agents","volume":"3","author":"Perez-Victoria","year":"2002","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.trstmh.2006.02.009_bib11","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1128\/AAC.47.8.2397-2403.2003","article-title":"Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug","volume":"47","author":"Perez-Victoria","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.trstmh.2006.02.009_bib12","doi-asserted-by":"crossref","first-page":"49965","DOI":"10.1074\/jbc.M308352200","article-title":"Functional cloning of the miltefosine transporter. A novel P-type phospholipid translocase from Leishmania involved in drug resistance","volume":"278","author":"Perez-Victoria","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.trstmh.2006.02.009_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/AAC.50.1.73-79.2006","article-title":"In vitro and in vivo interactions between miltefosine and other antileishmanial drugs","volume":"50","author":"Seifert","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.trstmh.2006.02.009_bib14","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0924-8579(03)00125-0","article-title":"Characterization of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine)","volume":"22","author":"Seifert","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.trstmh.2006.02.009_bib15","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1128\/AAC.44.12.3414-3424.2000","article-title":"Mefloquine pharmacokinetic-pharmacodynamic models: implications for dosing and resistance","volume":"44","author":"Simpson","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.trstmh.2006.02.009_bib16","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1086\/425359","article-title":"Oral miltefosine for leishmaniasis in immunocompromised patients: compassionate use in 39 patients with HIV infection","volume":"39","author":"Sindermann","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.trstmh.2006.02.009_bib17","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/383321","article-title":"Miltefosine for new world cutaneous leishmaniasis","volume":"38","author":"Soto","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.trstmh.2006.02.009_bib18","first-page":"394","article-title":"Availability of miltefosine for the treatment of kala-azar in India","volume":"83","author":"Sundar","year":"2005","journal-title":"Bull. World Health Organ"},{"key":"10.1016\/j.trstmh.2006.02.009_bib19","first-page":"301","article-title":"Delaying antimalarial drug resistance with combination chemotherapy","volume":"41","author":"White","year":"1999","journal-title":"Parassitologia"},{"key":"10.1016\/j.trstmh.2006.02.009_bib20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00003088-199937020-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether\u2013lumefantrine","volume":"37","author":"White","year":"1999","journal-title":"Clin. Pharmacokinet."}],"container-title":["Transactions of the Royal Society of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/trstmh\/article-pdf\/100\/Supplement_1\/S41\/5330254\/100-Supplement_1-S41.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T03:26:46Z","timestamp":1503545206000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/trstmh\/article-lookup\/doi\/10.1016\/j.trstmh.2006.02.009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":20,"alternative-id":["S0035920306001088"],"URL":"https:\/\/doi.org\/10.1016\/j.trstmh.2006.02.009","relation":{},"ISSN":["0035-9203"],"issn-type":[{"value":"0035-9203","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}